Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125435003 | 12543500 | 3 | F | 2016 | 20160727 | 20160711 | 20160729 | EXP | US-GILEAD-2016-0216298 | GILEAD | 55.00 | YR | A | F | Y | 72.56000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125435003 | 12543500 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Oral | 10 MG, QD | 22081 | 10 | MG | TABLET | QD | ||||||
| 125435003 | 12543500 | 2 | SS | AMBRISENTAN | AMBRISENTAN | 1 | 22081 | TABLET | |||||||||||
| 125435003 | 12543500 | 3 | SS | UPTRAVI | SELEXIPAG | 1 | Unknown | U | 0 | 400 | UG | BID | |||||||
| 125435003 | 12543500 | 4 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | Y | 0 | ||||||||||
| 125435003 | 12543500 | 5 | C | LASIX | FUROSEMIDE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 6 | C | KALEXATE | SODIUM POLYSTYRENE SULFONATE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 7 | C | ATROVENT | IPRATROPIUM BROMIDE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 8 | C | FLEXERIL | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 9 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 10 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 11 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 12 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 13 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 14 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 125435003 | 12543500 | 15 | C | K-DUR | POTASSIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125435003 | 12543500 | 1 | Pulmonary arterial hypertension |
| 125435003 | 12543500 | 2 | Hereditary haemorrhagic telangiectasia |
| 125435003 | 12543500 | 3 | Pulmonary hypertension |
| 125435003 | 12543500 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125435003 | 12543500 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125435003 | 12543500 | Chest pain | |
| 125435003 | 12543500 | Coronary artery disease | |
| 125435003 | 12543500 | Dyspnoea | |
| 125435003 | 12543500 | Headache | |
| 125435003 | 12543500 | Heart rate increased | |
| 125435003 | 12543500 | Pain in extremity | |
| 125435003 | 12543500 | Pulmonary arterial hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125435003 | 12543500 | 1 | 20130313 | 0 | ||
| 125435003 | 12543500 | 3 | 20160614 | 0 |